Mission Statement

The Vienna Faculty Center of Pharmaceutical Sciences aims to be recognized nationally and internationally as a leader in pharmaceutical research and education. We promote the discovery, development, and appropriate use of medications for the welfare and the safety of the public.

The range of topics in Pharmaceutical Sciences aims at the identification and the characterization of both new biologically active natural products and synthetic drugs and at understanding of their interactions with human targets on a molecular level using in silico, in vitro, and in vivo models.

Based on this knowledge, new lead compounds and disease relevant targets are investigated and delivery systems for pharmaceutical active ingredients are developed.

Different aspects of this range of topics have been defined as research focus like Drug Discovery from Nature, Computational Life Sciences and Nutrition-associated Molecular Mechanisms of Ageing and are represented e.g. in the doctoral program Molecular Drug Targets.

1 2 3 4 ...

Pharma and Food - Lecture Series

01.10.2020 - 21.01.2021

The upcoming lecture by Logan Hodgskiss (University of Vienna) on Oct 22 2020 will be presented online. Title: The Green Labs Austria Initiative.

Link to the online meeting: zoom.us/j/6104980010


Training the next generation of researchers and supporting young talents to become independent and internationally competitive is a central mission of the University of Vienna. The Vienna Doctoral School PhaNuSci serves as an umbrella for a structured doctoral education in pharma and food research. It is embedded in and adheres to the prinicipal rules and guidelines of the Doctoral Education Program of the University of Vienna.


Verena M. Dirsch (Department of Pharmacognosy) and Ina Bergheim (Department of Nutritional Sciences) have been granted an interdisciplinary research project within the Faculty of Life Sciences, entitled "Neolignans: new therapeutics in the prevention of diet-induced intestinal barrier dysfunction?" The main aim of the project is to determine if neolignans improve intestinal barrier function in settings of NAFLD and insulin resistance as well as to determine underlying molecular mechanisms.


Am 1. Mai sorgte die Zulassung des Medikaments Remdesivir in den USA für Schlagzeilen. Gerhard Ecker (Department für Pharmazeutische Chemie) erklärt im Interview die molekulare Basis der Remdesivir-Interaktion, die die Virenproduktion hemmen kann.


Challenged by an international examination commitee in front of screen and webcam, Manuel Matzinger brilliantly defended his thesis entitled "Impact of AMPK on the interactome and PTM pattern of Nrf2 and Development of an enrichment method for cross-linked peptides from a complex matrix” on May 4, 2020. Supervisor: Elke Heiss


A team led by Judith Rollinger (Department of Pharmacognosy) is screening traditional knowledge in order to identify new active substances against lung infections caused by influenza, coronavirus or pneumococci.

1 2 3 4 ...